Bahl Sunil, Biswal P, Sarkar S, Jenks Julie, Petersen Tim, Wenger Jay
NPSP-WHO, India.
J Indian Med Assoc. 2005 Dec;103(12):669-70, 678.
India has reached the final stage of polio eradication. The polio partnership in India, under the leadership of the Government of India, mounted tremendous response to the outbreak. The progress since 2003 is the most significant in the history of polio eradication in India. Surveillance sensitivity was increased to reach the goal for polio eradication. Since nearly all polio cases now occurring in India are caused by type 1 poliovirus in children, monovalent oral polio vaccine type 1 (mOPV1) was introduced in select high-risk districts of UP, Bihar and Mumbai-Thane during the April and May 2005 National Immunisation Days and the June and August 2005 in 6 sub-national immunisation rounds. Strategies were also being implemented to improve the impact of supplementary immunisation activities in the high-risk areas. As a result of supplementary immunisation activities targeted using surveillance data, India has made striking progress towards polio eradication.
印度已进入根除脊髓灰质炎的最后阶段。在印度政府的领导下,印度的脊髓灰质炎防治伙伴关系对疫情做出了巨大反应。自2003年以来取得的进展是印度脊髓灰质炎根除史上最为显著的。监测敏感性得以提高,以实现根除脊髓灰质炎的目标。由于目前印度几乎所有脊髓灰质炎病例都是由儿童中的1型脊髓灰质炎病毒引起的,因此在2005年4月和5月的全国免疫日以及2005年6月和8月的6次次国家级免疫活动中,在北方邦、比哈尔邦和孟买 - 塔纳的选定高风险地区引入了单价口服脊髓灰质炎疫苗1型(mOPV1)。还在实施各项战略,以提高高风险地区补充免疫活动的效果。通过利用监测数据开展有针对性的补充免疫活动,印度在根除脊髓灰质炎方面取得了显著进展。